Abingdon Health Plc
LSE: ABDX.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Christopher William Hand
- Employees
- 113
- Headquarters
- York, United Kingdom
- IPO year
- 2020
- Market cap
- £23.2M
- Website
- https://www.abingdonhealth.com
Loading ABDX…
Loading profile data…Frequently asked questions about ABDX
What does Abingdon Health Plc (ABDX.L) do?
Abingdon Health Plc develops, manufactures, and distributes diagnostic devices worldwide. It offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; Seralite, a rapid lateral flow test for the quantitative measurement of kappa and lambda immunoglobulin free light chains in serum; and AppDx, a customi...
Where does ABDX.L trade?
Abingdon Health Plc (ABDX.L) trades on the London Stock Exchange.
What sector is ABDX.L in?
Abingdon Health Plc (ABDX.L) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Abingdon Health Plc?
Christopher William Hand is the chief executive officer of Abingdon Health Plc (ABDX.L).
Where is Abingdon Health Plc headquartered?
Abingdon Health Plc is headquartered in United Kingdom.
Does ABDX.L pay a dividend?
Abingdon Health Plc (ABDX.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABDX.L go public?
Abingdon Health Plc (ABDX.L) completed its initial public offering in 2020.